4512.T लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 11:45):

Stats
आज की मात्रा	27 000.00
औसत मात्रा	153 089
बाजार मूल्य	7.95B
EPS	¥0 ( 2024-02-05 )
अगली कमाई की तारीख	( ¥0 ) 2024-05-12
Last Dividend	¥3.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-44.64
ATR14	¥0.376 (0.16%)

Wakamoto Pharmaceutical सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Wakamoto Pharmaceutical वित्तीय

Annual	2022
राजस्व:	¥8.66B
सकल लाभ:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
राजस्व:	¥8.66B
सकल लाभ:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
राजस्व:	¥8.38B
सकल लाभ:	¥4.36B (51.96 %)
EPS:	¥6.87

FY	2021
राजस्व:	¥8.89B
सकल लाभ:	¥4.49B (50.45 %)
EPS:	¥-17.34

Financial Reports:

No articles found.

Wakamoto Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥3.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Wakamoto Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.84 - average (61.59%) | Divividend Growth Potential Score: 3.11 - Decrease likely (37.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.50	2001-03-27
Last Dividend	¥3.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	¥45.50	--
Avg. Dividend % Per Year	0.00%	--
Score	1.71	--
Div. Sustainability Score	5.84
Div.Growth Potential Score	3.11
Div. Directional Score	4.47	--

Next Divdend (Est)
(2025-02-24)

¥0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.71

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8360.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7739.T	Ex Dividend Knight	2023-06-29	Semi-Annually	0.00%
6920.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
6279.T	Ex Dividend Knight	2024-02-19	Semi-Annually	0.00%
4996.T	Ex Dividend Knight	2023-10-30	Semi-Annually	0.00%
4204.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3402.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2491.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
9428.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
8084.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0223	1.500	-0.445	-0.668	[0 - 0.5]
returnOnAssetsTTM	-0.0116	1.200	-0.388	-0.466	[0 - 0.3]
returnOnEquityTTM	-0.0149	1.500	-1.277	-1.915	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.52	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.24	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.860	1.500	0.780	1.171	[0.2 - 2]
debtRatioTTM	0.00656	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	-264.52	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
freeCashFlowPerShareTTM	23.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00855	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.470	1.000	5.50	5.50	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0190	1.000	-2.38	-2.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	8.21	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.523	0.800	9.85	7.88	[0.5 - 2]
Total Score				5.84

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-44.73	1.000	-4.62	0	[1 - 100]
returnOnEquityTTM	-0.0149	2.50	-0.821	-1.915	[0.1 - 1.5]
freeCashFlowPerShareTTM	23.64	2.00	2.12	10.00	[0 - 30]
dividendYielPercentageTTM	1.310	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.063	1.500	6.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.93	0	[0.1 - 0.5]
Total Score				3.11

Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.